Dates and Times
End Date: 2/20/2012
ObjectivesUpon completion of this educational activity, the participant will be able to: 1.) Recognize signs of Dry Form of Macular Degeneration. 2.) Discuss treatment options for wet age-related macular degeneration (AMD). 3.) Review the use of photodynamic therapy in the treatment of Wet Form Macular Degeneration. 4.) Review the safety of ranibizumab in the treatment of wet age-related macular degeneration.
PDF of Slides
The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians
The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.